These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4349298)

  • 41. Hepatic drug metabolizing activity in lead-poisoned rats.
    Scoppa P; Roumengous M; Penning W
    Experientia; 1973 Aug; 29(8):970-2. PubMed ID: 4733318
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of some 6-substituted benzo(a)pyrene derivatives upon liver enzymes and ascorbic acid excretion in mice.
    Dewhurst F; Kitchen DA
    Biochem Pharmacol; 1973 Apr; 22(7):789-96. PubMed ID: 4144234
    [No Abstract]   [Full Text] [Related]  

  • 43. Interaction of calcium with microsomes: a modified method for the rapid isolation of rat liver microsomes.
    Kamath SA; Rubin E
    Biochem Biophys Res Commun; 1972 Oct; 49(1):52-9. PubMed ID: 4342728
    [No Abstract]   [Full Text] [Related]  

  • 44. Metabolism of drugs by subfractions of hepatic microsomes from prolonged ethanol-treated rats.
    Nakanishi S; Kinoshita G; Shioara E; Tsukada M
    Jpn J Pharmacol; 1972 Dec; 22(6):809-15. PubMed ID: 4541486
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of hepatic mixed function oxidase activity by propyl gallate.
    Yang CS; Strickhart FS
    Biochem Pharmacol; 1974 Nov; 23(22):3129-38. PubMed ID: 4155301
    [No Abstract]   [Full Text] [Related]  

  • 46. Sex-related differences in doxapram-induced alteration of drug action in the rat.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):397-400. PubMed ID: 2813960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of hexobarbital in primary cultures of rat hepatocytes maintains cytochrome P-450 levels and drug metabolizing enzyme activities.
    Kim HM; Ha JR; Park SK; Yang KH
    Drug Chem Toxicol; 1988; 11(1):29-41. PubMed ID: 3259924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mono-oxygenase activity in hepatic microsomes isolated by isoelectric precipitation.
    Fry JR; Bridges JW
    Anal Biochem; 1975 Jul; 67(1):309-18. PubMed ID: 807123
    [No Abstract]   [Full Text] [Related]  

  • 49. [Changes in the components of the hydroxylase system of the liver microsomes as a criterion in the assessment of the effects of vat dyes and azo compounds].
    Pashchenko EA; Kolodub FA; Vasilenko NM; Zvezdaĭ VI
    Gig Tr Prof Zabol; 1990; (5):52-4. PubMed ID: 2379857
    [No Abstract]   [Full Text] [Related]  

  • 50. Dieldrin and p,p'-DDT effects on some microsomal enzymes of livers of chickens and mallard ducks.
    Davison KL; Sell JL
    J Agric Food Chem; 1972; 20(6):1198-205. PubMed ID: 5083525
    [No Abstract]   [Full Text] [Related]  

  • 51. Dimethylaniline N-oxidase and aminopyrine N-demethylase activities of human liver tissue.
    Gold MS; Ziegler DM
    Xenobiotica; 1973 Mar; 3(3):179-89. PubMed ID: 4729682
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytochrome P-450 associated with free hepatic polyribosomes.
    Ichikawa Y; Mason HS
    Drug Metab Dispos; 1973; 1(1):62-5. PubMed ID: 4149421
    [No Abstract]   [Full Text] [Related]  

  • 53. Decrease in the substrate interaction with cytochrome P-450 in drug hydroxylation by liver microsomes from rats bearing Walker 256 carcinosarcoma.
    Kato R; Takanaka A; Takahashi A
    Gan; 1970 Aug; 61(4):359-65. PubMed ID: 5454683
    [No Abstract]   [Full Text] [Related]  

  • 54. Separation of hepatic smooth and rough microsomes associated with drug-metabolizing enzymes.
    Gram TE
    Methods Enzymol; 1974; 31():225-37. PubMed ID: 4423643
    [No Abstract]   [Full Text] [Related]  

  • 55. Relationship of dietary essential fatty acid consumption to hepatic drug hydroxylation.
    Wade AE; Wu B; Caster WO
    Pharmacology; 1972; 7(5):305-14. PubMed ID: 4644001
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of activities of drug-metabolizing enzymes in human fetal and adult livers.
    Pelkonen O; Kaltiala EH; Larmi TK; Kärki NT
    Clin Pharmacol Ther; 1973; 14(5):840-6. PubMed ID: 4147122
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibitors of hepatic mixed function oxidases--V. Inhibition of aminopyrine N-demethylation and enhancement of aniline hydroxylation by benzoxazole derivatives.
    Little PJ; Ryan AJ
    Biochem Pharmacol; 1982 May; 31(9):1795-8. PubMed ID: 7104044
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of adrenalectomy or alloxan diabetes on the substrate interaction with cytochrome P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Onoda K
    Biochem Pharmacol; 1971 Feb; 20(2):447-58. PubMed ID: 5150143
    [No Abstract]   [Full Text] [Related]  

  • 59. Lead and methyl mercury: effects of acute exposure on cytochrome P-450 and the mixed function oxidase system in the liver.
    Alvares AP; Leigh S; Cohn J; Kappas A
    J Exp Med; 1972 Jun; 135(6):1406-9. PubMed ID: 5025440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic microsomal ethanol oxidizing system (MEOS): differentiation from alcohol dehydrogenase and NADPH oxidase.
    Lieber CS; Rubin E; DeCarli LM
    Biochem Biophys Res Commun; 1970 Aug; 40(4):858-65. PubMed ID: 4395603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.